|Piper Jaffray 27th Annual Healthcare Conference|
|Panel Title:||“Underdiscovered NeuroInnovators”|
|Date:||Wednesday, December 2|
|Location:||Lotte New York Palace, New York, NY|
|Presenter:||Dr. Tomer Berkovitz, CFO|
About Alcobra Ltd.
Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of a proprietary drug candidate, MDX, to treat cognitive disorders including ADHD and FXS. For more information please visit the Company’s website, www.alcobra-pharma.com, the content of which is not incorporated herein by reference.